Literature DB >> 20924140

Lack of a primary physicochemical determinant in the direct transport of drugs to the brain after nasal administration in rats: potential involvement of transporters in the pathway.

Kyeong-Ryoon Lee1, Han-Joo Maeng, Jung-Byung Chae, Saeho Chong, Dae-Duk Kim, Chang-Koo Shim, Suk-Jae Chung.   

Abstract

The objectives of this study were to evaluate the relative contribution of the direct pathway in overall brain transport for 17 model drugs with different physicochemical properties after nasal administrations and to identify factors that govern the fraction of the dose transported to the brain via the direct pathway (F(a, direct)). When the model drugs were nasally administered to rats, 5 of the 17 model drugs were delivered to a significant extent to the brain via the direct pathway. Multiple linear regression analyses showed that the correlation between various physicochemical properties and F(a, direct) was not statistically significant, indicative of a lack of primary physicochemical determinants in the direct transport pathway. Transporters such as rOAT3 and rOCT2 were expressed at significant levels in rat olfactory epithelia, and uptakes of standard substrates were significantly decreased in HEK293 cells expressing rOAT3 and rOCT2 in the presence of the five model drugs that were delivered to appreciable extents to the brain via the direct pathway. Therefore, these observations indicate that carrier-mediated transport may play a role in the brain delivery of drugs from the nose via the direct transport pathway.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20924140     DOI: 10.2133/dmpk.dmpk-10-rg-049

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  5 in total

1.  Microarray Determination of the Expression of Drug Transporters in Humans and Animal Species Used for the Investigation of Nasal Absorption.

Authors:  Manar Al-Ghabeish; Todd Scheetz; Mahfoud Assem; Maureen D Donovan
Journal:  Mol Pharm       Date:  2015-07-10       Impact factor: 4.939

Review 2.  Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in Humans.

Authors:  Mitchel J R Ruigrok; Elizabeth C M de Lange
Journal:  AAPS J       Date:  2015-02-19       Impact factor: 4.009

3.  Direct nose to brain delivery of small molecules: critical analysis of data from a standardized in vivo screening model in rats.

Authors:  Deborah Dhuyvetter; Fetene Tekle; Maxim Nazarov; Rob J Vreeken; Herman Borghys; Frederik Rombouts; Ilse Lenaerts; Astrid Bottelbergs
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 4.  Cachexia: Pathophysiology and Ghrelin Liposomes for Nose-to-Brain Delivery.

Authors:  Cecilia T de Barros; Alessandra C Rios; Thaís F R Alves; Fernando Batain; Kessi M M Crescencio; Laura J Lopes; Aleksandra Zielińska; Patricia Severino; Priscila G Mazzola; Eliana B Souto; Marco V Chaud
Journal:  Int J Mol Sci       Date:  2020-08-19       Impact factor: 5.923

Review 5.  Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery.

Authors:  Thi-Thao-Linh Nguyen; Han-Joo Maeng
Journal:  Pharmaceutics       Date:  2022-03-05       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.